Author

C. E. Ozcelik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:virus· 1

Frequent Co-Authors

A. Ozkul· 2 shared A. Hanifehnezhad· 1 shared C. Z. Araz· 1 shared E. Sahin Kehribar· 1 shared E. U. Bozkurt· 1 shared K. Ergunay· 1 shared K. Foldes· 1 shared N. Filazi· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Ozkul

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Screening Peptide Drug Candidates to Neutralize Whole Viral Agents : A Case study with SARS-CoV-2 Virus

C. E. Ozcelik, C. Z. Araz, O. Yilmaz, S. Gulyuz, A. Ozkul, U. O. S. Seker

The paper uses M13 phage display to identify SARS-CoV-2 neutralizing peptides, finding three candidates with both binding and neutralizing capacity.

bioRxiv · Oct 22, 2023 · PreprintBioengineering

A Highly Potent SARS-CoV-2 Blocking Lectin Protein

R. E. Ahan, A. Hanifehnezhad, E. Sahin Kehribar, T. C. Oguzoglu, K. Foldes, C. E. Ozcelik, N. Filazi, S. Oztop, S. C. Onder, E. U. Bozkurt, K. Ergunay, A. Ozkul, U. Seker

This paper demonstrates that griffithsin (GRFT) blocks SARS-CoV-2 entry into cell lines and mouse models by binding to the spike protein, suggesting its potential as a prophylactic drug against SARS-CoV-2 variants.

bioRxiv · Jul 22, 2021Biochemistry